Skip to main content
. 2023 Aug 11;15(8):2124. doi: 10.3390/pharmaceutics15082124

Figure 3.

Figure 3

Active and passive forms of PSs or chemotherapeutics in combination with nanocarriers in melanoma PDT reproduced from ref. [36].